Cargando…

Novel pathways of HIV latency reactivation revealed by integrated analysis of transcriptome and target profile of bryostatin

The reactivation of HIV latency cell will be necessary to curing HIV infection. Although many latency-reversal agents (LRAs) have proven effective to reactivate the latency cell, there is a lack of any systematic analysis of the molecular targets of these LRAs and related pathways in the context of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing-xiang, Zhang, Han, Liu, Yubin, Li, Ya, Zheng, Jun-juan, Li, Wen-Xing, Feng, Kai, Sun, Ming, Dai, Shao-Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044323/ https://www.ncbi.nlm.nih.gov/pubmed/32103135 http://dx.doi.org/10.1038/s41598-020-60614-1

Ejemplares similares

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017)

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
por: Darcis, Gilles, et al.
Publicado: (2015)

Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion
por: Proust, Alizé, et al.
Publicado: (2017)

Bryostatin analog: improving on Nature's design
por: Boger, Dale
Publicado: (2012)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
por: Li, Shifei, et al.
Publicado: (2023)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Experimental Systems for Measuring HIV Latency and Reactivation
por: Fujinaga, Koh, et al.
Publicado: (2020)

Latency, Integration, and Reactivation of Human Herpesvirus-6
por: Pantry, Shara N., et al.
Publicado: (2017)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

β-catenin regulates HIV latency and modulates HIV reactivation
por: Barbian, Hannah J., et al.
Publicado: (2022)

Munc13 Is a Molecular Target of Bryostatin 1
por: Blanco, Francisco A., et al.
Publicado: (2019)

Bryostatin-1: a promising compound for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2023)

Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro
por: DeChristopher, Brian A., et al.
Publicado: (2012)

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
por: Martínez-Bonet, Marta, et al.
Publicado: (2015)

CpG Methylation Controls Reactivation of HIV from Latency
por: Blazkova, Jana, et al.
Publicado: (2009)

CpG methylation controls reactivation of HIV from latency
por: Blazkova, Jana, et al.
Publicado: (2010)

Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui
por: Wang, Pengfei, et al.
Publicado: (2017)

BK polyomavirus: latency, reactivation, diseases and tumorigenesis
por: Zhou, Xianfeng, et al.
Publicado: (2023)

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors
por: Thijsen, S F T, et al.
Publicado: (1999)

A phase II study of bryostatin 1 in metastatic malignant melanoma.
por: Propper, D. J., et al.
Publicado: (1998)

A transient heritable memory regulates HIV reactivation from latency
por: Lu, Yiyang, et al.
Publicado: (2021)

The nonequilibrium mechanism of noise-enhanced drug synergy in HIV latency reactivation
por: Guo, Xiaolu, et al.
Publicado: (2022)

Establishment of an In Vitro Model of Pseudorabies Virus Latency and Reactivation and Identification of Key Viral Latency-Associated Genes
por: Pan, Li, et al.
Publicado: (2023)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
por: Prendiville, J., et al.
Publicado: (1993)

Neristatin 1 Provides Critical Insight into Bryostatin 1 Structure–Function Relationships
por: Kedei, Noemi, et al.
Publicado: (2015)

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
por: Cogram, Patricia, et al.
Publicado: (2020)

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model
por: Mohammadi, Pejman, et al.
Publicado: (2014)

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
por: Méndez, Catalina, et al.
Publicado: (2018)

Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency
por: Gornalusse, Germán Gustavo, et al.
Publicado: (2021)

Epigenetic Control of Cytomegalovirus Latency and Reactivation
por: Liu, Xue-feng, et al.
Publicado: (2013)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

Centrosomal pre-integration latency of HIV-1 in quiescent cells
por: Zamborlini, Alessia, et al.
Publicado: (2007)

Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism
por: Díaz, Laura, et al.
Publicado: (2015)

A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency
por: Hafer, Terry L., et al.
Publicado: (2023)

A CRISPR screen of HIV dependency factors reveals CCNT1 is non-essential in T cells but required for HIV-1 reactivation from latency
por: Hafer, Terry L, et al.
Publicado: (2023)

A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
por: Madhusudan, S, et al.
Publicado: (2003)

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.
por: Thompson, C. H., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_16bt6qbe54k0h0sc2u28jb8iu7